Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Ricardo A Cruciani, Manuel Revuelta, Ella Dvorkin, Peter Homel, Pauline Lesage & Nora Esteban-Cruciani. (2015) L-carnitine supplementation in patients with HIV/AIDS and fatigue: a double-blind, placebo-controlled pilot study. HIV/AIDS - Research and Palliative Care 7, pages 65-73.
Read now
Read now
Ezequiel Ridruejo. (2015) Does hepatitis B virus therapy reduce the risk of hepatocellular carcinoma?. Expert Opinion on Drug Safety 14:3, pages 439-451.
Read now
Read now
Articles from other publishers (22)
Kerryn Drysdale, Jake Rance, Elena Cama, Carla Treloar & Limin Mao. (2022) What is known about the care and support provided for an ageing population with lived experience of chronic viral hepatitis as they near end‐of‐life: A scoping review. Health & Social Care in the Community 30:6.
Crossref
Crossref
Abhinav Kumar, Milan J. Sonneveld, Shao-Ming Chiu, Jun Y. Park, Sylvia M. Brakenhoff, Apichat Kaewdech, Wai-Kay Seto, Yasuhito Tanaka, Ivana Carey, Margarita Papatheodoridi, Florian van Bommel, Thomas Berg, Fabien Zoulim, Sang H. Ahn, George N. Dalekos, Nicole S. Erler, Christoph H. zu Siederdissen, Heiner Wedemeyer, Markus Cornberg, Man-Fung Yuen, Kosh Agarwal, Andre Boonstra, Maria Buti, Teerha Piratvisuth, George Papatheodoridis, Chien-Hung Chen & Benjamin Maasoumy. (2022) Probability of HBsAg Loss After Nucleo(s)tide Analogue Withdrawal Depends on HBV Genotype and Viral Antigen Levels. Journal of Clinical and Experimental Hepatology 12:5, pages 1385-1387.
Crossref
Crossref
Chantelli Iamblaudiot Razafindrazoto, Tovo Harimanana Rabenjanahary, Andry Lalaina Rinà Rakotozafindrabe, Sedera Radoniaina Rakotondrasoa, Nitah Harivony Randriamifidy, Anjaramalala Sitraka Rasolonjatovo, Soloniaina Hélio Razafimahefa & Rado Manitrala Ramanampamonjy. (2022) Effectiveness and Safety of Low Dose of Tenofovir Disoproxil Fumarate in Malagasy Patients with Chronic Hepatitis B. BioMed Research International 2022, pages 1-7.
Crossref
Crossref
Jayakrishna Ambati, Joseph Magagnoli, Hannah Leung, Shao-bin Wang, Chris A. Andrews, Dongxu Fu, Akshat Pandey, Srabani Sahu, Siddharth Narendran, Shuichiro Hirahara, Shinichi Fukuda, Jian Sun, Lekha Pandya, Meenakshi Ambati, Felipe Pereira, Akhil Varshney, Tammy Cummings, James W. Hardin, Babatunde Edun, Charles L. Bennett, Kameshwari Ambati, Benjamin J. Fowler, Nagaraj Kerur, Christian Röver, Norbert Leitinger, Brian C. Werner, Joshua D. Stein, S. Scott Sutton & Bradley D. Gelfand. (2020) Repurposing anti-inflammasome NRTIs for improving insulin sensitivity and reducing type 2 diabetes development. Nature Communications 11:1.
Crossref
Crossref
Mi Young Jeon, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Kwang‐Hyub Han, Sang Hoon Ahn & Seung Up Kim. (2020) Entecavir and tenofovir on renal function in patients with hepatitis B virus‐related hepatocellular carcinoma. Journal of Viral Hepatitis 27:9, pages 932-940.
Crossref
Crossref
Chun-Hsiang Wang, Kuo-Kuan Chang, Ruey-Chang Lin, Ming-Jeng Kuo, Chi-Chieh Yang & Yuan-Tsung Tseng. (2020) Consolidation period of 18 months no better at promoting off-treatment durability in HBeAg-positive chronic hepatitis B patients with tenofovir disoproxil fumarate treatment than a 12-month period. Medicine 99:18, pages e19907.
Crossref
Crossref
Ying Zhou, Rong Yan, Guo Qing Ru, Li Li Yu, Jiong Yao & Hong Wang. (2019) Pegylated-interferon consolidation treatment versus nucleos(t)ide analogue consolidation treatment in non-cirrhotic hepatitis B patients with hepatitis B e antigen seroconversion: an open-label pilot trial. Hepatology International 13:4, pages 422-430.
Crossref
Crossref
Grace Lai-Hung Wong, Henry Lik-Yuen Chan, Yee-Kit Tse, Terry Cheuk-Fung Yip, Kelvin Long-Yan Lam, Grace Chung-Yan Lui, Cheuk-Chun Szeto & Vincent Wai-Sun Wong. (2018) Chronic kidney disease progression in patients with chronic hepatitis B on tenofovir, entecavir, or no treatment. Alimentary Pharmacology & Therapeutics 48:9, pages 984-992.
Crossref
Crossref
G. L.-H. Wong, W.-K. Seto, V. W.-S. Wong, M.-F. Yuen & H. L.-Y. Chan. (2018) Review article: long-term safety of oral anti-viral treatment for chronic hepatitis B. Alimentary Pharmacology & Therapeutics 47:6, pages 730-737.
Crossref
Crossref
Thomas Berg, Karl-Georg Simon, Stefan Mauss, Eckart Schott, Renate Heyne, Dietmar M. Klass, Christoph Eisenbach, Tania Mara Welzel, Reinhart Zachoval, Gisela Felten, Julian Schulze-zur-Wiesch, Markus Cornberg, Marjoleine L. Op den Brouw, Belinda Jump, Hans Reiser, Lothar Gallo, Tobias Warger & Jörg Petersen. (2017) Long-term response after stopping tenofovir disoproxil fumarate in non-cirrhotic HBeAg-negative patients – FINITE study. Journal of Hepatology 67:5, pages 918-924.
Crossref
Crossref
Yao-Chun Hsu, Lein-Ray Mo, Chi-Yang Chang, Ming-Shiang Wu, Tzeng-Huey Yang, Jia-Horng Kao, Chieh-Chang Chen, Cheng-Hao Tseng, Chi-Ming Tai, Chih-Wen Lin, Chun-Ying Wu & Jaw-Town Lin. (2017) Serum viral load at the virological relapse predicts subsequent clinical flares in chronic hepatitis B patients off entecavir therapy. Journal of Gastroenterology and Hepatology 32:8, pages 1512-1519.
Crossref
Crossref
Seong Hee Kang, Keunhee Kang, Yeon Jong Eun, Young Sun Lee, Tae Suk Kim, Yang Jae Yoo, Sang Jun Suh, Eileen L. Yoon, Young Kul Jung, Ji Hoon Kim, Yeon Seok Seo, Hyung Joon Yim & Kwan Soo Byun. (2017) Antiviral response is not sustained after cessation of lamivudine treatment in chronic hepatitis B patients: A 10-year follow-up study. Journal of Medical Virology 89:5, pages 849-856.
Crossref
Crossref
Bircan Kayaaslan & Rahmet Guner. (2017) Adverse effects of oral antiviral therapy in chronic hepatitis B. World Journal of Hepatology 9:5, pages 227.
Crossref
Crossref
Ming-Tsung Lin, Yi-Hao Yen, Ming-Chao Tsai, Po-Lin Tseng, Kuo-Chin Chang, Cheng-Kun Wu & Tsung-Hui Hu. (2016) Comparison of the Efficacies and Safety of Combined Therapy between Telbivudine Plus Adefovir and Lamivudine Plus Adefovir in Patients with Hepatitis B Virus Infection in Real-World Practice. PLOS ONE 11:11, pages e0165416.
Crossref
Crossref
Diana Horta, Alberto Fernandez-Atutxa, Mireia Miquel, Mercedes Vergara, Meritxell Casas & Jordi S?nchez-Delgado. (2016) Resultados en la pr?ctica cl?nica del tratamiento de la hepatitis cr?nica por virus B con tenofovir y entecavir. Infectio 20:3, pages 123-129.
Crossref
Crossref
Grace Lai‐Hung Wong, Yee‐Kit Tse, Vincent Wai‐Sun Wong, Terry Cheuk‐Fung Yip, Kelvin Kam‐Fai Tsoi & Henry Lik‐Yuen Chan. (2015) Long‐term safety of oral nucleos(t)ide analogs for patients with chronic hepatitis B: A cohort study of 53,500 subjects. Hepatology 62:3, pages 684-693.
Crossref
Crossref
I-Cheng Lee, Cheuk-Kay Sun, Chien-Wei Su, Yuan-Jen Wang, Hung-Chuen Chang, Hui-Chun Huang, Kuei-Chuan Lee, Yi-Shin Huang, Chin-Lin Perng, Yuh-Hwa Liu, Chian-Sem Chua, Yu-Min Lin, Han-Chieh Lin & Yi-Hsiang Huang. (2015) Durability of Nucleos(t)ide Analogues Treatment in Patients With Chronic Hepatitis B. Medicine 94:32, pages e1341.
Crossref
Crossref
Ezequiel Ridruejo, Sebastián Marciano, Omar Galdame, María V. Reggiardo, Alberto E. Muñoz, Raúl Adrover, Daniel Cocozzella, Nora Fernandez, Claudio Estepo, Manuel Mendizabal, Gustavo A. Romero, Diana Levi, Teresa Schroder, Silvia Paz, Hugo Fainboim, Oscar G. Mandó, Adrián C. Gadano & Marcelo O. Silva. (2014) Efficacy and safety of long term entecavir in chronic hepatitis B treatment naïve patients in clinical practice. Annals of Hepatology 13:3, pages 327-336.
Crossref
Crossref
Marc M. Solomon, Javier R. Lama, David V. Glidden, Kathleen Mulligan, Vanessa McMahan, Albert Y. Liu, Juan Vicente Guanira, Valdilea G. Veloso, Kenneth H. Mayer, Suwat Chariyalertsak, Mauro Schechter, Linda-Gail Bekker, Esper Georges Kallás, David N. Burns & Robert M. Grant. (2014) Changes in renal function associated with oral emtricitabine/tenofovir disoproxil fumarate use for HIV pre-exposure prophylaxis. AIDS 28:6, pages 851-859.
Crossref
Crossref
Ezequiel Ridruejo. (2014) Antiviral treatment for chronic hepatitis B in renal transplant patients. World Journal of Hepatology 7:2, pages 189.
Crossref
Crossref
K.W. Cheung, M.T.Y. Seto & S.F. Wong. (2013) Towards complete eradication of hepatitis B infection from perinatal transmission: review of the mechanisms of in utero infection and the use of antiviral treatment during pregnancy. European Journal of Obstetrics & Gynecology and Reproductive Biology 169:1, pages 17-23.
Crossref
Crossref
Susanne Beckebaum, Iyad Kabar & Vito R. Cicinnati. (2012) Hepatitis B and C in liver transplantation: new strategies to combat the enemies. Reviews in Medical Virology 23:3, pages 172-193.
Crossref
Crossref